Review paper
Vaccine-attributable severe dengue in the Philippines
Abstract
In 2016, WHO1WHODengue vaccine: WHO position paper – July 2016.Wkly Epidemiol Rec. 2016; 91: 349-364PubMed Google Scholar recommended that the dengue vaccine CYD-TDV (Dengvaxia; Pasteur, Lyon, France), the first dengue vaccine, licensed for use in adults and children aged 9 years or older, be considered for use in highly endemic regions where at least 70% of 9-year-old children had previously been infected with dengue. The Philippines was the...
Paper Details
Title
Vaccine-attributable severe dengue in the Philippines
Published Date
Dec 1, 2019
Journal
Volume
394
Issue
10215
Pages
2151 - 2152
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History